Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28879064 | 1.00 | SIGMAR1 (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL4306865 | 1.00 | SIGMAR1 (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL2582965 | 1.00 | SIGMAR1 (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL3694249 | 1.00 | SIGMAR1 (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL11254111 | 1.00 | SIGMAR1 (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL6680431 | 1.00 | SIGMAR1 (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL6678927 | 1.00 | SIGMAR1 (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL1271432 | 0.97 | MAOA (0.58) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL11033070 | 0.95 | MAOA (0.56) | SIGMAR1MAOAMAOBMAPTRXFP1 | |
| SCHEMBL432616 | 0.90 | SIGMAR1 (0.54) | SIGMAR1MAOAMAOBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117779469-A | Construction method of host and guest of photodynamic/quaternary ammonium salt/boric acid antibacterial composite PET fiber coating | 浙江豪欣纺织有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-109422858-A | A kind of polyalcohol being grafted UV absorption agent molecule | 中国铁道科学研究院铁道建筑研究所 | 2019-03-05 | — | — | CN | claimed |
| CN-106398080-B | A kind of ammonium cross-linking type block copolymer/graphene composite material and preparation method thereof | 北京化工大学 | 2018-12-04 | — | — | CN | claimed |
| CN-106398080-A | Aminated cross-linked segmented copolymer/graphene composite material and preparation method thereof | 北京化工大学 | 2017-02-15 | — | — | CN | claimed |
| CN-103709110-B | A kind of preparation method of erlotinid hydrochloride key intermediate | APELOA KANGYU PHARMACEUTICAL CO., LTD. (CN) | 2016-05-04 | — | — | CN | claimed |
| US-20100223716-A1 | PROTECTIVE ARTICLES CONTAINING N-HALOCHITOSAN | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-09 | — | — | US | claimed |
| US-20080289088-A1 | N-ALKYLCHITOSAN FILMS AND LAMINATES MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-11-27 | — | — | US | claimed |
| US-7199043-B2 | Method of forming copper wiring in semiconductor device | HYNIX SEMICONDUCTOR INC. (KR) | 2007-04-03 | — | — | US | claimed |
| US-20050009339-A1 | Method of forming copper wiring in semiconductor device | KEY FOUNDRY CO., LTD. (KR) | 2005-01-13 | — | — | US | claimed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-117779469-A | Construction method of host and guest of photodynamic/quaternary ammonium salt/boric acid antibacterial composite PET fiber coating | 浙江豪欣纺织有限公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-112110864-B | 4-amide substituted pyrimidine targeted DDR1 inhibitor, preparation method thereof and application of inhibitor in antitumor activity | 温州医科大学 | 2022-07-22 | — | — | CN | disclosed |
| US-3933897-A | ANTIULCER, ASTHMA, RENAL DYSFUNCTION | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933898-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933896-A | ANTICOAGULANTS, ASTHMA, LABOR INDUCERS, CERVICAL DILATION | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933895-A | PROSTAGLANDINS, ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933899-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3931289-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | SIGMAR1 4651/4885MAOA 2124/4885MAOB 2543/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | SIGMAR1 4625/4885MAOA 2042/4885MAOB 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.